Search
Proteintech
ATXN10 Polyclonal Antibody
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Additional Information:
{{banner.description}}
Product Details
15693-1-AP
Applications
Tested Dilution
Publications
Product Specifications
Species Reactivity
Human,
Mouse,
Rat
Published species
Mouse
Host/Isotype
Rabbit
/ IgG
Class
Polyclonal
Type
Antibody
Immunogen
ATXN10 Fusion Protein Ag8259 (120-475 aa encoded by BC007508)
Conjugate
Form
Liquid
Concentration
0.22 mg/mL
Amount
33 µg
Purification
Antigen affinity chromatography
Storage buffer
PBS, pH 7.3, with 50% glycerol
Contains
0.02% sodium azide
Storage conditions
-20°C
Shipping conditions
Wet ice (domestic); Dry ice (international)
Product Specific Information
Immunogen sequence: ELRVEQESL LTAFRCGLQF LGNIASRNED SQSIVWVHAF PELFLSCLNH PDKKIVAYSS MILFTSLNHE RMKELEENLN IAIDVIDAYQ KHPESEWPFL IITDLFLKSP ELVQAMFPKL NNQERVTLLD LMIAKITSDE PLTKDDIPVF LRHAELIAST FVDQCKTVLK LASEEPPDDE EALATIRLLD VLCEMTVNTE LLGYLQVFPG LLERVIDLLR VIHVAGKETT NIFSNCGCVR AEGDISNVAN GFKSHLIRLI GNLCYKNKDN QDKVNELDGI PLILDNCNIS DSNPFLTQWV IYAIRNLTED NSQNQDLIAK MEEQGLADAS LLKKVGFEVE KKGEKLILKS TRDTPKP (120-475 aa encoded by BC007508 )
Target Information
The autosomal dominant cerebellar ataxias (ADCAs) are a clinically and genetically heterogeneous group of disorders characterized by ataxia, dysarthria, dysmetria, and intention tremor. All ADCAs involve some degree of cerebellar dysfunction and a varying degree of signs from other components of the nervous system. A commonly accepted clinical classification (Harding, 1993) divides ADCAs into 3 different groups based on the presence or absence of associated symptoms such as brainstem signs or retinopathy. The presence of pyramidal and extrapyramidal symptoms and ophthalmoplegia makes the diagnosis of ADCA I, the presence of retinopathy points to ADCA II, and the absence of associated signs to ADCA III. Genetic linkage and molecular analyses revealed that ADCAs are genetically heterogeneous even within the various subtypes.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Bioinformatics
Protein Aliases: ataxin 10 homolog; Ataxin-10; Brain protein E46; Brain protein E46 homolog; E46L; Neuronal beta-catenin-like protein; SCA10; spinocerebellar ataxia 10; spinocerebellar ataxia 10 homolog; Spinocerebellar ataxia type 10 protein; Spinocerebellar ataxia type 10 protein homolog; testis expressed gene 169; unnamed protein product
Gene Aliases: AI325283; ATX10; ATXN10; C77170; E46; E46L; HUMEEP; SCA10; TEG-169; Tex169
UniProt ID: (Human) Q9UBB4, (Rat) Q9ER24, (Mouse) P28658
Entrez Gene ID: (Human) 25814, (Rat) 170821, (Mouse) 54138
Disclaimer
Clicking the images or links will redirect you to a website hosted by BenchSci that provides third-party scientific content. Neither the content nor the BenchSci technology and processes for selection have been evaluated by us; we are providing them as-is and without warranty of any kind, including for use or application of the Thermo Fisher Scientific products presented.
Performance Guarantee
If an Invitrogen™ antibody doesn't perform as described on our website or datasheet,we'll replace the product at no cost to you, or provide you with a credit for a future purchase.*
Learn more
We're here to help
Get expert recommendations for common problems or connect directly with an on staff expert for technical assistance related to applications, equipment and general product use.
Contact tech support